Oncocyte Corp·4

Jun 27, 9:30 PM ET

KINGSLEY ALFRED D 4

4 · Oncocyte Corp · Filed Jun 27, 2023

Insider Transaction Report

Form 4
Period: 2023-06-23
Transactions
  • Award

    Option to Purchase Common Stock

    2023-06-23+90,00090,000 total
    Exercise: $0.20Exp: 2033-06-23Common Stock (90,000 underlying)
  • Award

    Common Stock, no par value

    2023-06-23+20,000489,111 total
Holdings
  • Common Stock, no par value

    (indirect: See Footnote)
    75,345
  • Common Stock, no par value

    (indirect: See Footnote)
    18,767
Footnotes (4)
  • [F1]The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.
  • [F2]The shares of common stock are held by Greenbelt Corp. The Reporting Person is the President of Greenbelt Corp. and in such capacity has the right to vote and dispose of the securities held by such entity.
  • [F3]The shares of common stock are held by Greenway Partners, LP. The Reporting Person is the General Partner of Greenway Partners, LP and in such capacity has the right to vote and dispose of the securities held by such entity.
  • [F4]Options shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.

Documents

1 file
  • 4
    ownership.xmlPrimary